Published in

American Society for Microbiology, Clinical and Vaccine Immunology, 5(17), p. 882-883, 2010

DOI: 10.1128/cvi.00038-10

Links

Tools

Export citation

Search in Google Scholar

High Levels of β- d -Glucan in Immunocompromised Children with Proven Invasive Fungal Disease

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Orange circle
Published version: archiving restricted
Data provided by SHERPA/RoMEO

Abstract

ABSTRACT The plasmatic levels of 1,3-β- d -glucan (BDG) were >523 pg/ml in 4 children, 2 low-birth-weight neonates and 2 stem cell transplant recipients, with the following invasive fungal diseases (IFD) proven apart from this BDG test: 3 cases of Candida parapsilosis candidemias and 1 case of disseminated aspergillosis. The BDG test may be useful for identification of IFD in pediatrics.